JNJ-17156516

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-17156516
Drug Alias NameCCK1 antagonist (J&J)JNJ-17156516
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin A receptor antagonists
TargetsCholecystokinin A receptor
Therapy Area/IndicationsPancreatitisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsPancreatitisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A